I have read with interest James C. Hurley's very good review \[[@B1-toxins-06-01362]\]. I totally agree that a reappraisal of the use of anti-endotoxin antibodies in Gram negative infections is warranted. In a study \[[@B2-toxins-06-01362]\] we showed the possible association between endotoxin (LPS) and morbidity and mortality in septic shock. This was a study in healthy primates (vervet monkeys). We found, when these anesthetized primates received an LD100 iv infusion of *Echerichia coli* (*E. coli*) over one hour, both *E. coli* and endotoxin concentration significantly increased during the *E. coli* infusion. The anti-endotoxin (anti-LPS) on the other hand decreased significantly. Interestingly, when the animals succumbed, their LPS concentration was still raised, but there were no viable *E. coli.* There was also only a small amount of anti-LPS present. Hence, endotoxin concentration rather than circulating *E. coli* bacteria may be an important pathogen responsible for the high mortality experienced during *E. coli* shock. This is in agreement with Spink *et al.* \[[@B3-toxins-06-01362]\] and now Hurley \[[@B1-toxins-06-01362]\] who suggested that endotoxin which forms an integral part of the outer cellular membrane of gram negative bacteria (GNB) participates in the genesis of shock.

In our review \[[@B4-toxins-06-01362]\] and some of the other papers we published in this field \[[@B5-toxins-06-01362],[@B6-toxins-06-01362],[@B7-toxins-06-01362],[@B8-toxins-06-01362],[@B9-toxins-06-01362]\], we refer to successful preliminary studies using anti-lipopolysaccharide IgG (anti-LPS). The anti-LPS both present prior to the insult or given after the insult, would seem to inactivate plasma endotoxins and combat Gram-negative bacteria in sepsis. Thereby, as Hurley \[[@B1-toxins-06-01362]\] suggests, may form part of a possible new form of therapy.

The question that needs to be addressed is: how best to accomplice this? What part of the endotoxin should be attacked, the *O*-specific chain or the smaller Lipid-A, or even, if possible, both?
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